Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Pharmacotherapy|November 11, 1999
Identification of a gemcitabine-warfarin interactionS A Kinikar, J M KolesarJournal of Capillary Electrophoresis|November 1, 1995
Quantitative analysis of NQO1 gene expression by RT-PCR and CE-LIFJ M Kolesar, J D Rizzo, J G KuhnJournal of Chromatography. B, Biomedical Sciences and Applications|October 29, 1997
Direct quantification of HIV-1 RNA by capillary electrophoresis with laser-induced fluorescenceJ M Kolesar, P G Allen, C M DoranJournal of Chromatography. B, Biomedical Sciences and Applications|September 14, 2000
Direct quantification of AD-36 adenovirus DNA by capillary electrophoresis with laser-induced fluorescenceJ M Kolesar, J A Miller, N V Dhurandhar, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 12, 2015
Assessment of adherence with oral anticancer agents in oncology clinical trials: A systematic reviewJ J Bergsbaken, J C Eickhoff, B A Buss, et al.Pharmacotherapy|December 22, 1999
Warfarin-5-FU interaction--a consecutive case seriesJ M Kolesar, C L Johnson, B L Freeberg, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 10, 2001
Transmissibility of adenovirus-induced adiposity in a chicken modelN V Dhurandhar, B A Israel, J M Kolesar, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|August 22, 2000
Increased adiposity in animals due to a human virusN V Dhurandhar, B A Israel, J M Kolesar, et al.Cancer Chemotherapy and Pharmacology|September 17, 2008
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignanciesY Xu, J M Kolesar, L J Schaaf, et al.Hematological Oncology|August 1, 2008
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network studyJ E Chang, P M Voorhees, J M Kolesar, et al.Pageof 2